Institution statistics

ACTELION PHARMACEUTICALS LTD - Switzerland

Ranking results:

Past rankings:

2008
Criterium:	Position:
Overall Score:	> 1000
Networking Rank (Reputation):	> 1000

Ranking timeline:

European project participation (2010-01-01 - 2021-12-31 ):

Performance:

Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:

Leadership:

Total number of projects: 1
As coordinator: 0
As participant: 1
Sole participant: 0
Coordinator / Participant Ratio: 0^*

^*Ratio includes only projects with > 2 partners

Summary:

	Total project funding [€]:				Projects [No]:
Year:	coordinator^*	participant^*	per partner		as coordinator	as participant
2016	0	6.000.000	0			1

^*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:

Institution:	Projects [No]:
ABBVIE	1
AMGEN LIMITED	1
ASTELLAS PHARMA EUROPE BV	1
ASTRAZENECA AB	1
BAYER PHARMA	1
CSL BEHRING	1
ELI LILLY AND COMPANY LIMITED	1
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM	1
ERASMUS UNIVERSITEIT ROTTERDAM	1
EUROPEAN CANCER PATIENT COALITION	1
EUROPEAN PATIENTS' FORUM	1
F HOFFMANNLA ROCHE	1
FEDERAAL KENNISCENTRUM VOOR DE GEZONDHEIDSZORG	1
INSTITUTO TUMORI ""GIOVANNI PAOLO II""	1
INTERNATIONAL ALLIANCE OF PATIENT'ORGANIZATIONS	1
ISTITUTO EUROPEO DI ONCOLOGIA	1
JANSSEN PHARMACEUTICA NV	1
KATHOLIEKE UNIVERSITEIT LEUVEN	1
MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN	1
MERCK SHARP & DOHME CORP	1
MINDBYTES	1
MUSCULAR DYSTROPHY GROUP OF GREAT BRITAIN AND NORTHERN IRELAND	1
NOVARTIS PHARMA	1
PFIZER LIMITED	1
SANOFIAVENTIS RECHERCHE & DEVELOPPEMENT	1
STEINBEISSER PROJECT MANAGEMENT UG	1
TAKEDA DEVELOPMENT CENTRE EUROPE	1
UNIVERSITAIR MEDISCH CENTRUM UTRECHT	1
UNIVERSITATSKLINIKUM ERLANGEN	1
UNIVERSITY OF BIRMINGHAM	1
UNIVERSITY OF NEWCASTLE UPON TYNE	1
UPPSALA UNIVERSITET	1

Constancy:

Total number of partners:32

Partner loyalty:
Frequent Partner: (> 2 projects): 0
Rare Partner: 32

Frequent / Rare Partner Ratio: 0

Diversity:

Subjects:

Subject:	No:

Diversity index:0

Categories:

Category:	No:

Project overview:

Start date	Project	acronym	role	funding	partners
2016-10-01	Patient Preferences in benefit risk assessments during the drug life cycle - Sofia ref.: 115966	PREFER	participant	6.000.000	33

Data provision: © European Union; Source: CORDIS, http://cordis.europa.eu/ | This page is not provided by the European Commission see:Impressum